Cargando…

Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma

Immune checkpoint inhibitors (ICIs) have been used for the treatment of various types of cancers, including malignant melanoma. Mechanistic exploration of tumor immune responses is essential to improve the therapeutic efficacy of ICIs. Since tumor immune responses are based on antigen-specific immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Kenta, Okuyama, Ryuhei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658693/ https://www.ncbi.nlm.nih.gov/pubmed/36361781 http://dx.doi.org/10.3390/ijms232112991

Ejemplares similares

Late Onset of Cardiac Metastasis of a Melanoma following Nivolumab Immunotherapy
por: Nakamura, Kenta, et al.
Publicado: (2022)

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
por: Kiniwa, Yukiko, et al.
Publicado: (2021)

Role of Innate Immune Cells in Psoriasis
por: Sato, Yuki, et al.
Publicado: (2020)

BRAF Mutation Heterogeneity in Melanoma Lesions
por: SAKAIZAWA, Kaori, et al.
Publicado: (2020)

Nivolumab in the treatment of malignant melanoma: review of the literature
por: Mashima, Emi, et al.
Publicado: (2015)

Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review
por: Okuyama, Sonia, et al.
Publicado: (2010)

Significance of 5-S-Cysteinyldopa as a Marker for Melanoma
por: Wakamatsu, Kazumasa, et al.
Publicado: (2020)

Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination
por: Katsuie, Shiho, et al.
Publicado: (2022)

Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer
por: Yoshida-Court, Kyoko, et al.
Publicado: (2023)

Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
por: Öjlert, Åsa Kristina, et al.
Publicado: (2021)

Immune repertoire profiling for disease pathobiology
por: Katoh, Hiroto, et al.
Publicado: (2022)

Malignant Melanoma
por: Perera, Eshini, et al.
Publicado: (2013)

Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
por: OSAWA, Kana, et al.
Publicado: (2022)

Cnidarian Immunity and the Repertoire of Defense Mechanisms in Anthozoans
por: Parisi, Maria Giovanna, et al.
Publicado: (2020)

Thigmotropism of Malignant Melanoma Cells
por: Quatresooz, Pascale, et al.
Publicado: (2012)

Cellular immunity in human malignant melanoma and melanoma histology.
por: Cameron-Mowat, D. E., et al.
Publicado: (1973)

Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma
por: Saito, Ryuichi, et al.
Publicado: (2021)

Response in Immune Repertoires
por: Walczak, Aleksandra M.
Publicado: (2021)

Malignant Melanoma
por: Ortega Candil, Aída, et al.
Publicado: (2012)

Utility of Melanin Degradation Products in the Nail for Diagnosing Nail Apparatus Melanoma
por: MIYAKE, Tomomi, et al.
Publicado: (2021)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

Simulants of Malignant Melanoma
por: Piérard, Gérald E., et al.
Publicado: (2015)

Using T‐cell repertoire profiles as predictor in a primary mucosal melanoma
por: Chang, Che‐Mai, et al.
Publicado: (2020)

Innate Lymphoid Cells in the Malignant Melanoma Microenvironment
por: Apraiz, Aintzane, et al.
Publicado: (2020)

Malignant Fibrous Histiocytoma with In-Transit Metastasis
por: Fujimura, Taku, et al.
Publicado: (2011)

Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma
por: Scirka, Bozena, et al.
Publicado: (2017)

Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma
por: Si, Mengqing, et al.
Publicado: (2022)

Deciphering Repertoire of B16 Melanoma Reactive TCRs by Immunization, In Vitro Restimulation and Sequencing of IFNγ-Secreting T Cells
por: Izosimova, Anna V., et al.
Publicado: (2021)

High‐throughput sequencing of immune repertoires in multiple sclerosis
por: Lossius, Andreas, et al.
Publicado: (2016)

Malignant melanoma in a grey horse: case presentation and review of equine melanoma treatment options
por: Metcalfe, Lucy VA, et al.
Publicado: (2013)

Human Malignant Melanoma
por: MacKie, R. M.
Publicado: (1979)

The size of the immune repertoire of bacteria
por: Bradde, Serena, et al.
Publicado: (2020)

The clinical features and optimal treatment of anorectal malignant melanoma
por: Nam, Soomin, et al.
Publicado: (2014)

The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
por: Ernst, Madison, et al.
Publicado: (2022)

Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
por: Ruck, Tobias, et al.
Publicado: (2022)

Familial Malignant Melanoma - Overview
por: Dębniak, Tadeusz
Publicado: (2004)

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022)

CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model
por: Furusawa, Aki, et al.
Publicado: (2022)

Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
por: Ellingsen, Espen Basmo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hhak4v0b113tltu4771hk6k57s